Clinical Trial Update: Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mometasone furoate (SCH 032088) with beclomethasone dipropionate or placebo in seasonal allergic rhinitis; results completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Beclomethasone Dipropionate (beclomethasone dipropionate)
• Mometasone furoate (SCH 032088) (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2019-08-09